Commentary: The role of toxicology in prevention and precaution

International Journal of Occupational Medicine and Environmental Health

Volumn 17, Issue 1, 2004, Pages 91-102

  Silbergeld, Ellen K ^a,b  

^a The Johns Hopkins University   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Precaution; Prevention; Risk assessment; Toxicology

Indexed keywords

CONFERENCE PAPER; OCCUPATIONAL MEDICINE; TOXICOLOGY;

EID: 1842784863     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (54)

1. United Nations Conference on Environment and Development. Rio Declaration on Environmental and Development. Rio de Janeiro, 1992 [cited 2003 Jun 27]. Available from: http://www.upnep.org/Documents/Default.asp?DocumentID=78&ArticleID=1163.
2. McGinn AP. Why poison ourselves? A precautionary approach to synthetic chemicals. World Watch Paper 153, November 2000.
3. European Environment Agency. Late lessons from early warnings: the precautionary principle 1896-2000. Environmental Issue Report No. 22. Copenhagen: European Environment Agency; 2001.
4. Raffensperger C, Tickner J. Protecting Public Health and the Environment: Implementing the Precautionary Principle. Washington, DC: Island Press; 1999.
5. O'Brien M. Making Better Environmental Decisions. Cambridge: MIT Press; 1999.
6. Wahlstrom B. The precautionary approach to chemicals management: a Swedish perspective. In: Raffensperger C, Tickner J, editors. Protecting Public Health and the Environment: Implementing the Precautionary Principle. Washington, DC: Island Press; 1999. p. 51-69.
7. Barrett K, Raffensperger C. Precautionary science. In: Raffensperger C, Tickner J, editors. Protecting Public Health and the Environment: Implementing the Precautionary Principle. Washington, DC: Island Press; 1999. p. 106-22.
8. Kriebel D, Tickner J, Epstein P, Lemons J, Levins R, Loechler EL, et al. The precautionary principle in environmental science. Environ Health Perspect 2001; 109 9): 871-6.
9. Data Quality Act. Public Law 2000, 106-554.
10. Silbergeld EK. Protection of the public interest, allegations of scientific misconduct, and the Needleman case. Am J Public Health 1995; 85 (2):165-6.
11. Silbergeld EK. Understanding risk: The case of dioxin. Sci Am Sci Med 1995; Nov/Dec: 48-57.
12. Stolley PD, Lasky T. Investigating Disease Patterns. The Science of Epidemiology. New York: WH Freeman and Company; 1995.
13. Davies JC, Mazurek J. Pollution Control in the United States. Evaluating the System. Washington, DC: Resources for the Future; 1998.
14. Silbergeld EK. The role of toxicology in causation: A scientific perspective. Courts Health Science Law 1991; 1: 374-85.
15. Huff J. IARC Monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. Int J Occup Environ Health 2002; 8(3): 249-70.
16. IARC Monogrphs on the Evaluation of Carcinogenic Risks to Humans. Vol. 69. Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans. Lyon: International Agency for Research on Cancer; 1997.
17. Ames BN, Gold LS. Mitogenesis, mutagenesis, and animal cancer tests [Review]. Prog Clin Biol Res 1991; 369:1-20.
18. Sewall CH, Lucier GW. Receptor-mediated events and the evaluation of the Environmental Protection Agency (EPA) of dioxin risks. Mutat Res 1995; 333(1-2): 111-22.
19. Coggins CRE. A review of the chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol Pathol 1998; 26: 307-14.
20. Cole CE, Tran HT, Schlosser PM. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo. J Toxicol Environ Health A 2001; 62 (6): 439-65.
21. Farris GM, Robinson SN, Gaido KW, Wong BA, Wong VA, Hahn WP, et al. Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice. Fundam Appl Toxicol 1997; 36(2): 119-29.
22. Gebel TW. Unanswered questions in arsenic toxicology. J Environ Pathol Toxicol Oncol 2001; 20(4): 299-309.
23. Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 2002; 23(8): 1387-97.
24. Capen CC, Dybing E, Rice JM, et al., editors. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. IARC Scientific Publications No. 147. Lyon: International Agency for Research on Cancer; 1999.
25. Silbergeld EK. Preventing lead poisoning in children. Ann Rev Public Health 1997; 18: 187-210.
26. Goldsmith JR, Hexter AC. Lead intake from food and from the atmosphere. Science 1968; 159(818): pp. 1000.
27. De la Burde B, Choate MS, Jr. Does asymptomatic lead exposure in children have latent sequelae? J Pediatr 1972; 81(6): 1088-91.
28. Needleman HL, Tuncay OC, Shapiro IM. Lead levels in deciduous teeth of urban and suburban American children. Nature 1972; 235(5333): 111-2.
29. Silbergeld EK, Goldberg AM. Lead-induced behavioral dysfunction: an animal model of hyperactivity. Exp Neurol 1974; 42(1): 146-57.
30. Silbergeld EK, Adler HS. Subcellular mechanisms of lead neurotoxicity. Brain Res 1978; 148(2): 451-67.
31. Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, et al. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 1979; 300(13): 689-95.
32. Settle DM, Patterson CC. Lead in albacore: guide to lead pollution in Americans. Science 1980; 207(4436): 1167-76.
33. Bellinger DC, Needleman HL. Lead and the relationship between maternal and child intelligence. J Pediatr 1983; 102(4): 523-7.
34. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics 1992; 90(6): 855-61.
35. Bellinger D, Sloman J, Leviton A, Rabinowitz M, Needleman HL, Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics 1991; 87(2): 219-27.
36. Aldridge WN. The biological basis and measurement of thresholds. Ann Rev Pharmacol Toxicol 1986; 26: 39-58.
37. Charles GD, Linscombe VA, Tornsi B, Mattsson JL, Gollapudi BB. An in vitro screening paradigm for extracts of whole foods for detection of potential toxicants. Food Chem Toxicol 2002; 40(10): 1391-402.
38. Silbergeld EK. The hazards of synthetic (anthropogenic) chemicals. Toxicol Letters 1995; 82/83: 835-41.
39. About Chemical Industries Institute of Toxicology [cited Oct 2002]. Available from: http://www.ciit.org.
40. Swenberg JA, Lehman-McKeeman LD. α2-Urinary globulin -associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. In: Capen CC, Dybing E, Rice JM, et al., editors. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. IARC Scientific Publication No. 147. Lyon: International Agency for Research on Cancer; 1999. 95-118.
41. Irons RD. Studies on the mechanism of 1,3-butadiene-induced leukemogenesis: the potential role of endogenous murine leukemia virus. Environ Health Perspect 1990; 86: 49-55.
42. Dorman DC, Brenneman KA, McElveen AM, Lynch SE, Roberts KC, Wong BA. Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rat brain. J Toxicol Environ Health A 2002; 65(20): 1493-511.
43. Silbergeld EK. Risk assessment: the perspective and experience of US environmentalists. Environ Health Perspect 1993; 101(2): 100-4.
44. U.S. Environmental Protection Agency. Chemical right-to-know initiative [cited Oct 2002]. Available from: http://www.epa.gov/chemrtk.
45. Environmental Defense. Toxic Ignorance: the continuing absence of basic health testing for top-selling chemicals in the United States. Washington: Environmental Defense; 1997.
46. National Research Council (NRC). Toxicity testing: strategies to determine needs and priorities. Washington, DC: National Academy Press; 1984.
47. Olden K, Guthrie J, Newton S. A bold new direction for environmental health research. Am J Public Health 2001; 91(12): 1964-7.
48. Waring JF, Halbert DN. The promise of toxicogenomics. Curr Opin Mol Ther 2002; 4(3): 229-35.
49. Goldberg AM, Frazier JM. Alternatives to animals in toxicity testing. Sci Am 1989; 261(2): 24-30.
50. Green S, Goldberg AM, Zurlo J. The TestSmart-HPVProgram-development of an integrated approach for testing high production volume chemicals. Regul Toxicol Pharmacol 2001; 33(2): 105-9.
51. Balls M, Goldberg AM, Fentem JH, Broadhead CL, Burch RL, Festing MF, et al. The three Rs: the way forward: the report and recommendations of ECVAM Workshop 11. Altern Lab Anim 1995; 23(6): 838-66.
52. Seiler A, Visan A, Pohl I, Genschow E, Buesen R, Spielmann H. Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells). ALTEX 2002; 19 Suppl 1: 55-63.
53. Giesy JP, Kannan K. Distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001; 35(7): 1339-42.
54. Olsen GW, Burris J, Mandel JH, Zobel LR. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med 1999; 41(9): 799-806.